Industry and News Prostate Cancer Diagnostics Market | Page 3

The North American region consists of the U.S., and Canada. Latin America region consists of Mexico
and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The
Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India,
ASEAN, Australia & New Zealand. The Middle East and Africa region consists of GCC, South Africa
and North Africa.
In case of geographical region, U.S. is expected to account a major share of the Prostate Cancer
Diagnostics Market. Some of the key players that fuel the growth of the Prostate Cancer Diagnostics
Market include Genomic Health, Abbott, OPKO, Siemens Healthcare, DiaSorin, bioMeriux, Roche,
MDx Health, Beckman Coulter, Myriad Genetics, Ambry Genetics, and others.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/therapeutic-area
Market Segment:
Global Prostate Cancer Diagnostics market competition by top manufacturers, with production,
price, revenue (value) and market share for each manufacturer; the top players including
• Genomic Health
• Abbott
• OPKO
• Siemens Healthcare
• DiaSorin
• bioMeriux
• Roche
• MDx Health